These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18342171)

  • 41. C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.
    Lehrer S; Diamond EJ; Mamkine B; Droller MJ; Stone NN; Stock RG
    BJU Int; 2005 May; 95(7):961-2. PubMed ID: 15839913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
    Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
    Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
    Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate-specific antigen velocity in healthy Korean men with initial PSA levels of 4.0 ng/mL or less.
    Ham WS; Kang DR; Kim YS; Seong do H; Kim SJ; Cheon SH; Cho IR; Cho JS; Kim CI; Choi YD
    Urology; 2008 Jul; 72(1):99-103. PubMed ID: 18533237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
    Seo HK; Chung MK; Ryu SB; Lee KH;
    Urology; 2007 Dec; 70(6):1109-12. PubMed ID: 18158028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
    Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between serum prostate specific antigen level and prostate volume in a community-based cohort: large-scale screening of 35,223 Korean men.
    Park DS; Hong JY; Hong YK; Lee SR; Hwang JH; Kang MH; Kwon SW; Oh JJ
    Urology; 2013 Dec; 82(6):1394-9. PubMed ID: 24295251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percent free prostate specific antigen does not enhance the specificity of total prostate specific antigen for the detection of prostate cancer in Korean men 50 to 65 years old: a prospective multicenter study.
    Jeong IG; Lee KH;
    J Urol; 2008 Jan; 179(1):111-6. PubMed ID: 17997422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
    Grigor'ev ME; Mazo EB; Chekhonin VP
    Urol Nefrol (Mosk); 1998; (4):33-7. PubMed ID: 9727319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate biopsy in patients with long-term use of indwelling bladder catheter: what is the rationale?
    Antunes AA; Barbosa JA; Reis ST; Guariero MS; Fukushima JT; Dall'oglio MF; Freire Gde C; Lucon AM; Leite KR; Srougi M
    Urol Oncol; 2012 Sep; 30(5):620-3. PubMed ID: 20933446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Data analysis of the objective observation parameters of benign prostatic hyperplasia patients accepting different treatment regimens].
    Zhang YG; Wang JY; Liu M; Wan B; Wei D; Deng SM; Xu J; Wu JY; Chu X; Zeng P
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1690-2. PubMed ID: 19024540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of prostate volume based on total and free serum prostate-specific antigen: is it reliable?
    Morote J; Encabo G; López M; de Torres IM
    Eur Urol; 2000 Jul; 38(1):91-5. PubMed ID: 10859448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer?
    Chang SG; Kim CS; Jeon SH; Kim YW; Choi BY
    Int J Urol; 2006 Feb; 13(2):122-6. PubMed ID: 16563135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Correlation of benign prostatic hyperplasia with hyperlipemia].
    Li PJ; Zhang XH; Guo LJ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):387-9. PubMed ID: 15854349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
    Fujimoto K; Hirao Y; Masumori N; Arai Y; Yamanaka H; Kato T; Miyazawa K
    Int J Urol; 2006 May; 13(5):543-9. PubMed ID: 16771723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
    Walz J; Haese A; Scattoni V; Steuber T; Chun FK; Briganti A; Montorsi F; Graefen M; Huland H; Karakiewicz PI
    Cancer; 2008 Nov; 113(10):2695-703. PubMed ID: 18853417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum prostate-specific antigen is better correlated to body surface area than body mass index in a population of healthy Korean men.
    Song M; Doo SW; Yang WJ; Song YS; Kim Y
    Int J Urol; 2010 Jun; 17(6):580-3. PubMed ID: 20370844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum PSA and transition zone index as predictors of acute urinary retention in benign prostate hyperplasia].
    Zhu S; Chen S; Li Q; Lin Z; Zheng S; Weng M
    Zhonghua Nan Ke Xue; 2004 Jan; 10(1):24-5. PubMed ID: 14979202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.